Cost-effectiveness of the regimen proposed by the International Consortium on Acute Promyelocytic Leukemia for the treatment of newly diagnosed patients with Acute Promyelocytic Leukemia-Reference-Cited by-同舟云学术

Cost-effectiveness of the regimen proposed by the International Consortium on Acute Promyelocytic Leukemia for the treatment of newly diagnosed patients with Acute Promyelocytic Leukemia

Published:2021-10 Issue:4 Volume:43 Page:476-481
ISSN:2531-1379
Container-title:Hematology, Transfusion and Cell Therapy
language:en
Short-container-title:Hematology, Transfusion and Cell Therapy

Author:

Rodríguez-Rodríguez Sergio^ORCID,Guerrero-Torres Lorena^ORCID,Díaz-Huízar María José,Pomerantz Alan,Ortíz-Vilchis María del Pilar,Demichelis-Gómez Roberta

Publisher

Elsevier BV

Subject

Hematology,Immunology and Allergy

Reference23 articles.

1. Acute coronary syndrome manifesting as an adverse effect of all-trans-retinoic acid in acute promyelocytic leukemia: a case report with review of the literature and a spotlight on management;Govind Babu;Case Rep Oncol Med,2016

2. Curative strategies in acute promyelocytic leukemia;Tallman;Hematology Am Soc Hematol Educ Program,2008

3. Improving acute promyelocytic leukemia (APL) outcome in developing countries through networking, results of the International Consortium on APL;Rego;Blood,2013

4. Budgetary impact of treating acute promyelocytic leukemia patients with first-line arsenic trioxide and retinoic acid from an Italian payer perspective;Kruse;PLoS ONE,2015

5. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia;Meng-Er;Blood,1988

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The potential of photodynamic therapy in current breast cancer treatment methodologies;Biomedicine & Pharmacotherapy;2021-05